Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy.

Landim-Vieira, Maicon; Kahmini, Aida Rahimi; Engel, Morgan; Cannon, Elisa Nicole; Amat-Alarcon, Nuria; Judge, Daniel P; Pinto, José Renato; Chelko, Stephen P

Landim-Vieira, Maicon; Kahmini, Aida Rahimi; Engel, Morgan; Cannon, Elisa Nicole; Amat-Alarcon, Nuria; Judge, Daniel P; Pinto, José Renato; Chelko, Stephen P.

Affiliation

Landim-Vieira M; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Kahmini AR; Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA.
Engel M; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Cannon EN; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Amat-Alarcon N; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 21215, USA.
Judge DP; Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Pinto JR; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Chelko SP; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.

Int J Mol Sci ; 23(22)2022 Nov 11.

Article de En | MEDLINE | ID: mdl-36430389

Sujet(s)
Mots clés

ARBs; PPARs; arrhythmogenic cardiomyopathy; fibrosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cardiopathies / Cardiomyopathies Type d'étude: Etiology_studies / Prognostic_studies Limites: Animals Langue: En Journal: Int J Mol Sci Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google